CHNC - Alpha Research Institute Update

About this update from Cannabis Bioscience International Holdings, Inc.

[{"type":"text","content":"\n HOUSTON, TX, Nov. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – China Infrastructure Construction Corp (OTC: CHNC) From my desk… It is with great pleasure that I take a moment out of my day to write this letter to respond and/or clarify one of the most frequent questions that our shareholders have submitted requesting information about. Our shareholders have shown interest in further exploring and/or understanding the portion under which we conduct our clinical trials and our development of these projects. Alpha Research Institute, one of CHNC’s branches and a Houston-based research facility, is currently active and continues to become one of the top research centers in Houston. Several clinical trials take place in Alpha on a daily basis, these are research studies in which people volunteer to find new treatments and ways to improve public health problems, through procedures monitored by doctors and health professionals bound to FDA’s guidelines. Furthermore, Alpha’s team is responsible for planning, setting up, and executing day-to-day management of the contracted clinical trials. Every single study is different, so to supply these services, our multidisciplinary team must meticulously read, analyze, comprehend, apply and work under the rules and terms of various protocols. These protocols act as a baseline for establishing our target patient audience so that the results of these studies are adapted to the specific research needs of our sponsors, guaranteeing patient safety and the proper development of each procedure. Our research center has a highly professional relationship with its sponsors marked by confidentiality, which is why we cannot answer some of the questions and disclose certain information that could harm our company or others as most of the guidelines belong to the intellectual property of our sponsors. However, we are glad to share the information we can disclose. At present, Alpha has 15 clinical trials available and open for patient recruitment. These studies include: Children's biological sample collection, Rheumatoid Arthritis, Active infection (STD), Chronic Diarrhea, Adult biological sample collection, Diabetic retinopathy, Celiac disease, Suspected infection, and five different cancer studies (which once more we cannot name due to our confidentiality agreements), Chron...

More updates from Cannabis Bioscience International Holdings, Inc.